Iambic raises over $100 million in an oversubscribed round, supported by numerous investors to advance its AI-discovered therapeutics and platform technologies.
Amount Raised
$100 Million
Round Type
Funding Round
Investors
Description
Iambic announced raising over $100 million in an oversubscribed financing round. The funding was supported by a mix of new and existing investors including Abingworth and Sequoia. The company aims to further develop its AI-driven discovery platform. This fundraise reflects the significant progress made across its pipeline and partnerships.
Quick answer
Iambic Therapeutics raised $100 Million in a Funding Round round, dated November 10, 2025. Investors: Sequoia Capital, Wilson Sonsini Goodrich & Rosati, Terra Magnum Capital Partners, Tao Capital Partners, Regeneron Ventures, Qatar Investment Authority, Pegasus Tech Ventures and Mubadala. Iambic Therapeutics is based in San Diego, California, United States.
- How much did Iambic Therapeutics raise?
- Iambic Therapeutics raised $100 Million in a Funding Round round on November 10, 2025.
- Who invested in Iambic Therapeutics?
- Sequoia Capital, Wilson Sonsini Goodrich & Rosati, Terra Magnum Capital Partners, Tao Capital Partners, Regeneron Ventures, Qatar Investment Authority, Pegasus Tech Ventures and Mubadala are named as investors in this round.
- What does Iambic Therapeutics do?
- Iambic is a clinical-stage life-science and technology company developing novel medicines using its AI-driven discovery and development platform.
- Where is Iambic Therapeutics based and how big is it?
- Iambic Therapeutics is based in San Diego, California, United States. Fundz records about 119 employees.
- Who are the decision-makers at Iambic Therapeutics?
- Fundz holds 2 contacts at Iambic Therapeutics, including the Co-founder and CTO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Iambic Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Holobiome raised $10M on December 24, 2025.
- DP Technology raised $114M (Series C) on December 24, 2025.
- SI Group raised $150M (Funding Round) on December 24, 2025.
- GPN Vaccines raised $3.5M on December 24, 2025.
- Kashiv BioSciences raised $72M (Debt Financing) on December 23, 2025.
- Vyriad raised $25M (Series B) on December 23, 2025.
Who to call at Iambic Therapeutics, and when
A new round usually means Iambic Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Iambic Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Iambic Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Iambic Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Iambic Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Iambic Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.